Objectives: Chronic inflammatory diseases are associated with an accelerated atherosclerotic process. Recent studies have discussed whether inflammatory bowel diseases (IBDs) can predict early atherosclerosis. We investigated this possibility. Methods: The study consisted of IBD cases (group 1, n = 40) and healthy persons (group 2, n = 40). The IBD group was selected so as not to have vascular disease or the presence of established major cardiovascular risk factors. Results: Group 1 cases showed a significant increase in carotid intima media thickness (cIMT; P = .01). Carotid artery stiffness was impaired in group 1 (P = .03) and high-sensitivity C-reactive protein (hsCRP), homeostasis model assessment of insulin resistance (HOMA-IR), and homocysteine (Hyc) were higher in group 1 patients (P = .02, P = .03, P = .05). Conclusions: Inflammatory bowel disease patients have an increased risk of early atherosclerosis as shown by greater values of cIMT, carotid artery stiffness, Hyc, hsCRP, and insulin resistance.
Hatoum OA, Binion DGThe vasculature and inflammatory bowel disease: contribution to pathogenesis and clinical pathology. Inflamm Bowel Dis. 2005;11(3):304-313.
2.
Danesh J., Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med . 2004;350(14):1387-1397.
3.
Papa A., Santoliquido A., Danese S., et al. Increased carotid intima-media thickness in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2005 ;22(9): 839-846.
4.
Danese S., Sgambato A., Papa A., et al. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Am J Gastroenterol. 2005;100(4): 886-895.
5.
Bregenzer N. , Hartmann A., Strauch U., Schölmerich J., Andus T., Bollheimer LCIncreased insulin resistance and beta cell activity in patients with Crohn’s disease. Inflamm Bowel Dis. 2006;12(1):53-56.
6.
Van Doornum S., McColl G., Wicks IPAccelerated atherosclerosis. An extraarticular feature of rheumatoid arthritis? Arthritis Rheum. 2002;46(4):862-873.
7.
Roman MJ, Shanker B-A., Davis A., et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003;349(25): 2399-2406.
8.
Gazi IF, Boumpas DT, Mikhailidis DP, Ganotakis ESClustering of cardiovascular risk factors in rheumatoid arthritis: the rationale for using statins. Clin Exp Rheumatol. 2007 ;25(1):102-111.
9.
Touboul PJClinical impact of intima media measurement. Eur J Ultrasound . 2002;16(1-2):105-113.
10.
O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr.Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999;340(1): 14-22.
11.
Roman MJ, Devereux RB, Schwartz JE, et al. Arterial stiffness in chronic inflammatory diseases. Hypertension. 2005;46(1):194-199.
12.
Lentz SRMechanisms of homocysteine-induced atherothrombosis. J Thromb Haemost. 2005;3(8):1646-1654.
13.
Maharshak N. , Arbel Y., Bornstein NM, et al. Inflammatory bowel disease is not associated with increased intimal media thickening. Am J Gastroenterol . 2007;102(5): 1050-1055.
14.
Willinek WA , Ludwing M., Lennarz M., Höller T., Stumpe KOHigh-normal serum homocysteine concentrations are associated with an increased risk of early atherosclerotic carotid artery wall lesions in healthy subjects. J Hypertens. 2000;18(4):425-430.
15.
Bland JM, Altman DGStatistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307-310.
16.
Peterson LN , Jensen RE, Parnell R.Mechanical properties of arteries in vivo . Circ Res. 1960;8:622-639.
17.
Matthews DR , Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RCHomeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419.
18.
Karlinger K. , Gyorke T., Mako E., Mester A., Tarján Z.The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol. 2000;35(3):154-167.
Papa A., Danese S., Urgesi R., et al. Early atherosclerosis in patients with inflammatory bowel disease . Eur Rev Med Pharmacol Sci. 2006;10(1):7-11.
22.
Laurent S., Boutouyrie P., Asmar R., et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension . 2001;37(5):1236-1241.
23.
Haverkate F. , Thompson SG, Pyke SD, Gallimore JR, Pepys MBProduction of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet. 1997;349(9050): 426-462.
24.
Hu G., Qiao Q., Tuomilehto J., Eliasson M., Feskens EJ, Pyörälä K.DECODE Insulin Study GroupPlasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies. Diabetologia. 2004;47(7):1245-1256.
25.
Enas A., Garg A., Davidson MA, Nair VM, Huet BA, Yusuf S.Coronary heart disease and its risk factors in first generation immigrant Asian Indians to the United State of America. Indian Heart J. 1996;48(4):343-353.
26.
Rantala AO, Paivansalo M., Kauma H., et al. Hyperinsulinemia and carotid atherosclerosis in hypertensive and control subjects. Diabetes Care. 1998;21(7):1188-1193.
Howard G., O’Leary DH, Zaccaro D., et al. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation. 1996;93(10):1777-1779;1809-1819.
29.
Jhamb R., Gaiha M., Chakravarti A., Daga MKInsulin resistance/hyperinsulinemia as a risk factor for common carotid artery intima media thickness in essential hypertension. J Indian Acad Clin Med. 2005;6(2):122-128.
30.
Grundy SM, Howard B., Smith S. Jr, Eckel R., Redberg R., Bonow ROPrevention Conference, VI: Diabetes and cardiovascular disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation . 2002;105(18):2231-2239.
31.
Capristo E. , Mingrone G., Addolorato G., Greco AV, Gasbarrini G.Glucose metabolism and insulin sensitivity in inactive inflammatory bowel disease. Aliment Pharmacol Ther. 1999;13(2):209-217.
32.
Danese S., Papa A., Saibeni S., Repici A., Malesci A., Vecchi M.Inflammation and coagulation in inflammatory bowel disease: the clot thickens . Am J Gastroenterol. 2007;102(1):174-186.
33.
van Wersch JWJ , Houben P., Rijken J.Platelet count, platelet function, coagulation activity and fibrinolysis in the acute phase of inflammatory bowel disease . J Clin Chem Clin Biochem. 1990;28(8):513-517.
34.
Kocaman O., Sahin T., Aygun C., Senturk O., Hulagu S.Endothelial dysfunction in patients with ulcerative colitis. Inflamm Bowel Dis. 2006;12(3):166-171.
35.
De Leeuw K. , Kallenberg C., Bijl M.Accelerated atherosclerosis in patients with systemic autoimmune diseases. Ann N Y Acad Sci. 2005;1051:362-371.
